Sunrest Lifescie — 360° view

Sunrest Lifescie, a company in the Pharmaceuticals industry, reported revenue of ₹32 crore and net profit of ₹0.94 crore for the September 2026 quarter.

Sunrest Lifescie (NSE: SUN-RE-ST) closed at ₹36.00. Its market capitalisation is ₹15 crore and it trades at 5.5 times earnings.

Share price
₹36.00
Market cap
₹15 Cr
P/E
5.55
Revenue
₹32 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
23.2% (FY26)
ROE
15.2% (FY26)
Book value
₹46.5 (FY26)
Dividend yield
0.00% (last 12 months)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SUN-RE-ST

Incorporated in 2017, Sunrest Lifescience Ltd trades in Health care and Cosmetics products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.